Skip to content

Serotonin: all studies

Page 147 of 400: studies 1,461 to 1,470 of 3,999, newest first. Back to the serotonin overview

Research

Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat

Behavioural Processes June 6, 2015 Aline Pic‐taylor, Luciana Gueiros Da Motta, Juliana Alves de Morais et al. 99 citations

Ayahuasca, a psychoactive beverage used by indigenous and religious groups, is generally prepared by the coction of Psychotria viridis and Banisteriopsis caapi plants containing N,N-dimethyltryptamine (DMT) and β-carboline alkaloids, respectively. To investigate the acute toxicity of ayahuasca, the infusion was administered by gavage to female Wistar rats at doses of 30X and 50X the dose taken...

Research on Acute Toxicity and the Behavioral Effects of Methanolic Extract from Psilocybin Mushrooms and Psilocin in Mice

Toxins March 27, 2015 О. В. Жук, Іzabela Jasicka-Misiak, Anna Poliwoda et al. 64 citations

The pharmacological activities and acute toxicity of the psilocin (PC) and dried residues of the crude extracts of psychotropic mushrooms were investigated in mice. The hallucinogenic substances were effectively isolated, by using methanol, from the species of Psilocybe semilanceata and Pholiotina cyanopus, that were collected in the north-east region of Poland. The chemical analysis of these...

5HT2a Receptors – a New Target for Depression?

European Psychiatry March 1, 2015 D. Nutt 3 citations

Cortical 5HT2A receptors are largely expressed in layer 5 pyramidal neurons and appear to play a pivotal role in brain function in that they gate top-down descending inputs to local cortical microcircuits. There is evidence that they may play a role in depression in that the number of these receptors is increased in some people with depression and the augmenting action of atypical...

Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signalling

Swiss Medical Weekly January 11, 2015 Matthias E. Liechti 188 citations

Novel psychoactive substances are newly used designer drugs ("internet drugs", "research chemicals", "legal highs") potentially posing similar health risks to classic illicit substances. Chemically, many novel psychoactive substances can be classified as phenethylamines, amphetamines, synthetic cathinones, piperazines, pipradrols/piperidines, aminoindanes benzofurans, and tryptamines....

DOI: 10.4414/smw.2015.14043 (opens in new tab) Serotonin Pharmacology Designer drug Monoamine neurotransmitter +1

Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects

Biological Psychiatry November 29, 2014 Yasmin Schmid, Florian Enzler, Peter Gasser et al. 425 citations

BackgroundAfter no research in humans for >40 years, there is renewed interest in using lysergic acid diethylamide (LSD) in clinical psychiatric research and practice. There are no modern studies on the subjective and autonomic effects of LSD, and its endocrine effects are unknown. In animals, LSD disrupts prepulse inhibition (PPI) of the acoustic startle response, and patients with...

The effect of particular active substances of hallucinogenic mushrooms

Acta Universitatis Lodziensis Folia Biologica et Oecologica November 26, 2014 Marek Wieczorek 4 citations

Magic mushrooms have accompanied man for thousands of years. Formerly they were used for religious and culture purposes. Those fungi belong mainly to the genera Conocybe, Copelandia, Panaeolus, Psilocybe and Stropharia. A number of these fungal species produce substances, like psilocybin, psilocin, ibotenic acid or muscimol. Because of their chemical similarity to naturally occurring...

Effects of MDMA on body temperature in humans

Temperature October 31, 2014 Matthias E. Liechti 64 citations

Hyperthermia is a severe complication associated with the recreational use of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy). In this review, the clinical laboratory studies that tested the effects of MDMA on body temperature are summarized. The mechanisms that underlie the hyperthermic effects of MDMA in humans and treatment of severe hyperthermia are presented. The data show that MDMA...

Synthesis, characterization, and monoamine transporter activity of the new psychoactive substance 3′,4′‐methylenedioxy‐4‐methylaminorex (MDMAR)

Drug Testing and Analysis October 20, 2014 Gavin McLaughlin, Noreen Morris, Pierce V. Kavanagh et al. 18 citations

The recent occurrence of deaths associated with the psychostimulant cis-4,4'-dimethylaminorex (4,4'-DMAR) in Europe indicated the presence of a newly emerged psychoactive substance on the market. Subsequently, the existence of 3,4-methylenedioxy-4-methylaminorex (MDMAR) has come to the authors' attention and this study describes the synthesis of cis- and trans-MDMAR followed by extensive...

Psilocybin and Obsessive Compulsive Disorder

Journal of Psychoactive Drugs October 20, 2014 James A. Wilcox 55 citations

Obsessive Compulsive Disorder (OCD) is a psychiatric disorder with considerable morbidity and mortality. This condition disables many individuals and is often refractory to treatment. Research suggests that serotonin plays a role in OCD symptom reduction. We present a case of an individual who successfully used psilocybin, a serotonergic agent, to reduce the core symptoms of OCD for several...

Characterization of a novel and potentially lethal designer drug (±)‐cis‐para‐methyl‐4‐methylaminorex (4,4'‐DMAR, or ‘Serotoni’)

Drug Testing and Analysis May 19, 2014 Simon D. Brandt, Michael H. Baumann, John S. Partilla et al. 37 citations

During the second half of 2013, a total of 26 deaths involving para-methyl-4-methylaminorex (4,4'-DMAR) were reported to the European Monitoring Centre for Drugs and Drug Addiction. While aminorex and 4-methylaminorex (4-MAR) are known psychostimulants, nothing is known about the comparatively new para-methyl analog. Analytical characterization of two independent samples obtained from online...

DOI: 10.1002/dta.1668 (opens in new tab) Full text (opens in new tab) Serotonin Designer drug Amphetamine Monoamine neurotransmitter +7